Evolent Health (EVH) Tops Q3 EPS by 24c

Evolent Health (NYSE: EVH) reported Q3 EPS of $0.11, $0.24 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $60.2 million versus the consensus estimate of $58.35 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• Home Depot beats estimates, reaffirms fiscal 2026 guidance